Jagsonpal Pharma may be a multibagger
Posted: Thu Nov 07, 2024 8:12 pm
Jagsonpal Pharma has investments by Mukul Agrawal (₹28 Cr), Lincoln Coelho (₹19 Cr) & Sanjay Dangi (Authum) (₹23 Cr). M-Cap is ₹1600 Cr. Promoters hold 68%. Co is Debt-Free. RoCE is 18%. It has a portfolio of drugs focusing on Gynecology & Orthopedic with many leading brands
